HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Men’s Grooming In Africa; Beiersdorf Reports FY 2014; More

This article was originally published in The Rose Sheet

Executive Summary

Market research firms identify men’s grooming in Africa and specialized facial skin-care offerings as opportunities for personal-care firms. More news in brief.

You may also be interested in...



Germany’s OTC Market In 2023: Cough, Cold & Flu and Probiotics Drove Steady Growth

German consumers are “generally willing to accept price increases from OTC manufacturers” when it comes to core categories like cough, cold & flu, finds Sempora, and are increasingly willing to shell out for trending gut health products like probiotics.

FDA Delay Will Not Push Rocket Pharma Off Its Trajectory

The gene therapy company could have two products approved by the end of 2024 – with ambitions for long-term expansion beyond rare disease.

UTC’s Suit Against US FDA To Block Application For Tyvaso Rival Invokes Arcane ‘Bundling Rule’

United Therapeutics Corp. claims the agency wrongly allowed Liquidia to submit an amendment to add a new indication to its tentatively approved NDA for a rival version of its pulmonary arterial hypertension blockbuster treprostinil.

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS019579

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel